Merck shares dive after multiple firms downgrade on cancer drug withdrawal – CNBC
CNBC Merck shares dive after multiple firms downgrade on cancer drug withdrawalCNBCMerck announced lung cancer trial result delays and that it was pulling its application to market key oncology drug Keytruda for lung cancer in the EU on Friday. Analysts at Morgan Stanley, Barclays and SunTrust Robinson Humphrey all downgraded the …Merck's Price Strength Is […]
